Significant Pharmaceuticals Reported in US Patents

Significant Pharmaceuticals Reported in US Patents
Author: Thomas F. DeRosa
Publsiher: Elsevier
Total Pages: 700
Release: 2010-07-07
Genre: Science
ISBN: 0080480918

Download Significant Pharmaceuticals Reported in US Patents Book in PDF, Epub and Kindle

Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications. Pharmaceuticals are reported for 27 separate classes of illness, including: AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders. Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students. Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications. Identifies next generation pharmaceuticals Provides practical preparation methods for each active agent and derivatives Documents the analytical characterization and biological testing results of active agents

Advances in Synthetic Organic Chemistry and Methods Reported in US Patents

Advances in Synthetic Organic Chemistry and Methods Reported in US Patents
Author: Thomas F. DeRosa
Publsiher: Elsevier
Total Pages: 704
Release: 2006-03-21
Genre: Science
ISBN: 0080455638

Download Advances in Synthetic Organic Chemistry and Methods Reported in US Patents Book in PDF, Epub and Kindle

Advances in Synthetic Organic Chemistry and Methods Reported in US Patents provides synthetic guidelines for preparing current and commercially significant organic compounds, derivatives, and intermediates as reported in issued US Patents. Industries surveyed include agrochemical, cosmetics and personal care products. Each entry contains extensive information such as explicit laboratory directions for preparing all chemical intermediates and characterization data. Furthermore, product optimization studies, industrial preparation, and new synthetic methods have been included for selected entries, as well as projected research directions for future product development. In Advances in Synthetic Organic Chemistry and Methods Reported in US Patents the author's practical approach enables readers to identify research and market trends, and stay up-to-date on current developments in the field. Provides synthetic guidelines for preparing current and commercially significant organic compounds, derivatives, and intermediates as reported in issued US Patents Identifies product development trends to help determine research areas Elucidates use of the US Patent and Trademark Office database

Next Generation of International Chemical Additives

Next Generation of International Chemical Additives
Author: Thomas F. DeRosa
Publsiher: Elsevier
Total Pages: 578
Release: 2012-10-11
Genre: Science
ISBN: 9780444537898

Download Next Generation of International Chemical Additives Book in PDF, Epub and Kindle

The objective is writing ‘Next Generation Chemical Additives’ to identify the next generation chemical additives for eight selected industries. The text will also provide methods for their preparation, additive treatment levels, and testing methods to evaluate additive performance. To ensure optimum performance of materials and products, chemists, formulators, and blenders must be provided with the most current information on existing chemical additives. It is even more essential that corporate operations officers can easily identify the next generation of chemical additives. In addition to this a critical comparison will be given with the existing additives. Structural and physical properties as well as low and elevated temperature toxicity information provided in an easy to understand format Highlights the advantages of the selected additive over existing agents Applications using the newly identified chemical additive provided for existing commercial materials and products The most direct method for preparing the chemical agent described Simplistic and sophisticated method for characterizing the chemical agent provided

Advances in Polymer Chemistry and Methods Reported in Recent US Patents

Advances in Polymer Chemistry and Methods Reported in Recent US Patents
Author: Thomas F. DeRosa
Publsiher: John Wiley & Sons
Total Pages: 760
Release: 2008-09-16
Genre: Science
ISBN: 9780470385982

Download Advances in Polymer Chemistry and Methods Reported in Recent US Patents Book in PDF, Epub and Kindle

The objective of this book is to convey to academic and industrial researchers and students advances in synthetic and characterization methods in 9 selected areas of polymer chemistry reported in 2007-2008 US Patents. It reviews the impact of newer bulk anionic, cationic, and free radical polymerization methods within selected industrial applications. Bulk and surface crosslinking agents using selected bi- and tri-functional reagents, photochemical methods, or free radical agents are also reviewed. Finally, there is a separate section on cationic and cationic ring opening polymerization reactions describing di- and tri-heterocyclic monomers and their use in medical devices.

The Political Economy of Pharmaceutical Patents

The Political Economy of Pharmaceutical Patents
Author: Sherry S. Marcellin
Publsiher: Routledge
Total Pages: 226
Release: 2016-02-24
Genre: Political Science
ISBN: 9781317020790

Download The Political Economy of Pharmaceutical Patents Book in PDF, Epub and Kindle

This book provides a fresh, multidisciplinary, and exciting look at the making and remaking of pharmaceutical patents at the GATT/WTO, by utilising a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin focuses on the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement and consequently, the role of the African Group at the WTO in the remaking of those patent provisions.

Patents and Pharmaceutical Drugs

Patents and Pharmaceutical Drugs
Author: Julio J. Nogués
Publsiher: World Bank Publications
Total Pages: 41
Release: 1990
Genre: Drugs
ISBN: 9182736450XXX

Download Patents and Pharmaceutical Drugs Book in PDF, Epub and Kindle

Medical Monopoly

Medical Monopoly
Author: Joseph M. Gabriel
Publsiher: University of Chicago Press
Total Pages: 328
Release: 2014-10-24
Genre: Medical
ISBN: 9780226108216

Download Medical Monopoly Book in PDF, Epub and Kindle

During much of the nineteenth century, physicians and pharmacists alike considered medical patenting and the use of trademarks by drug manufacturers unethical forms of monopoly; physicians who prescribed patented drugs could be, and were, ostracized from the medical community. In the decades following the Civil War, however, complex changes in patent and trademark law intersected with the changing sensibilities of both physicians and pharmacists to make intellectual property rights in drug manufacturing scientifically and ethically legitimate. By World War I, patented and trademarked drugs had become essential to the practice of good medicine, aiding in the rise of the American pharmaceutical industry and forever altering the course of medicine. Drawing on a wealth of previously unused archival material, Medical Monopoly combines legal, medical, and business history to offer a sweeping new interpretation of the origins of the complex and often troubling relationship between the pharmaceutical industry and medical practice today. Joseph M. Gabriel provides the first detailed history of patent and trademark law as it relates to the nineteenth-century pharmaceutical industry as well as a unique interpretation of medical ethics, therapeutic reform, and the efforts to regulate the market in pharmaceuticals before World War I. His book will be of interest not only to historians of medicine and science and intellectual property scholars but also to anyone following contemporary debates about the pharmaceutical industry, the patenting of scientific discoveries, and the role of advertising in the marketplace.

Coalitions and Compliance

Coalitions and Compliance
Author: Kenneth C. Shadlen
Publsiher: Oxford University Press
Total Pages: 328
Release: 2017-08-04
Genre: Political Science
ISBN: 9780191612275

Download Coalitions and Compliance Book in PDF, Epub and Kindle

Coalitions and Compliance examines how international changes can reconfigure domestic politics. Since the late 1980s, developing countries have been subject to intense pressures regarding intellectual property rights. These pressures have been exceptionally controversial in the area of pharmaceuticals. Historically, fearing the economic and social costs of providing private property rights over knowledge, developing countries did not allow drugs to be patented. Now they must do so, an obligation with significant implications for industrial development and public health. This book analyses different forms of compliance with this new imperative in Latin America, comparing the politics of pharmaceutical patenting in Argentina, Brazil, and Mexico. Coalitions and Compliance focuses on two periods of patent politics: initial conflicts over how to introduce drug patents, and then subsequent conflicts over how these new patent systems function. In contrast to explanations of national policy choice based on external pressures, domestic institutions, or Presidents' ideological orientations, this book attributes cross-national and longitudinal variation to the ways that changing social structures constrain or enable political leaders' strategies to construct and sustain supportive coalitions. The analysis begins with assessment of the relative resources and capabilities of the transnational and national pharmaceutical sectors, and these rival actors' efforts to attract allies. Emphasis is placed on two ways that social structures are transformed so as to affect coalition-building possibilities: how exporters fearing the loss of preferential market access may be converted into allies of transnational drug firms, and differential patterns of adjustment among state and societal actors that are inspired by the introduction of new policies. It is within the changing structural conditions produced by these two processes that political leaders build coalitions in support of different forms of compliance.

Intellectual Property Law and Access to Medicines

Intellectual Property Law and Access to Medicines
Author: Srividhya Ragavan,Amaka Vanni
Publsiher: Routledge
Total Pages: 522
Release: 2021-07-28
Genre: Law
ISBN: 9781000398700

Download Intellectual Property Law and Access to Medicines Book in PDF, Epub and Kindle

The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property (IP) rights to the present, this book documents the role of different sets of actors – states, transnational business corporations, or civil society groups – and their influence on the structures – such as national and international agreements, organizations, and private entities – that have caused changes to healthcare and access to medication. Presenting the debates over patents, trade, and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), as it galvanized non-state and nonbusiness actors, the book highlights how an alternative framing and understanding of pharmaceutical patent rights emerged: as a public issue, instead of a trade or IP issue. The book thus offers an important analysis of the legal and political dynamics through which the contest for access to lifesaving medication has been, and will continue to be, fought. In addition to academics working in the areas of international law, development, and public health, this book will also be of interest to policy makers, state actors, and others with relevant concerns working in nongovernmental and international organizations.

Drug Prices

Drug Prices
Author: Kevin J. Hickey,Kevin T. Richards
Publsiher: Unknown
Total Pages: 58
Release: 2021
Genre: Drugs
ISBN: OCLC:1274040129

Download Drug Prices Book in PDF, Epub and Kindle

How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry

How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry
Author: Anna Cook
Publsiher: U.S. Government Printing Office
Total Pages: 75
Release: 1998
Genre: Competition
ISBN: PURD:32754071785707

Download How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry Book in PDF, Epub and Kindle

Trade Agreements Patents and Drug Prices

Trade Agreements  Patents  and Drug Prices
Author: Amy Kapczynski
Publsiher: Unknown
Total Pages: 10
Release: 2017
Genre: Electronic Book
ISBN: OCLC:1305322944

Download Trade Agreements Patents and Drug Prices Book in PDF, Epub and Kindle

The upward-ratcheting of patent protection through trade agreements has generated significant concerns about potential effects on prices of drugs and access to medicines in developing countries. The Trans-Pacific Partnership (TPP) included even more extensive pharmaceutical patent provisions than any before. While President Trump withdrew the US as a signatory to the TPP, the potential for new trade agreements to raise the same set of concerns generated by the TPP remains high. Previous work assessing the TPP argued that new data on pharmaceutical expenditures (and other measures) from countries with recent trade agreements with the U.S. indicated that concerns about pharmaceutical patent protection and drug prices are overblown and it may be time to move on from these debates. Here we argue that the analysis supporting these claims is misleading because it fails to look at the right drugs at the right points in time, overlooks the temporal dimensions of implementation of provisions in previous trade agreements, and ignores the broader context in which trade agreements are negotiated and implemented. Much more empirical work is needed to understand the impact of previous trade agreements, and the effects of stronger patent protections in developing countries on innovation, access, and prices. Some of the crucial analyses may not be possible until the provisions in the agreements take full effect, which could take some time especially in developing countries where patenting is relatively new.

PAREXEL s Pharmaceutical R D Statistical Sourcebook

PAREXEL s Pharmaceutical R   D Statistical Sourcebook
Author: Anonim
Publsiher: Unknown
Total Pages: 135
Release: 2002
Genre: Drugs
ISBN: UCLA:L0086634268

Download PAREXEL s Pharmaceutical R D Statistical Sourcebook Book in PDF, Epub and Kindle

INNOVATION ECONOMIC DEVELOPMENT AND INTELLECTUAL PROPERTY IN INDIA AND

INNOVATION  ECONOMIC DEVELOPMENT  AND INTELLECTUAL PROPERTY IN INDIA AND
Author: Kung-Chung Liu,Uday S. Racherla
Publsiher: Springer Nature
Total Pages: 514
Release: 2019-01-01
Genre: Development economics
ISBN: 9789811381027

Download INNOVATION ECONOMIC DEVELOPMENT AND INTELLECTUAL PROPERTY IN INDIA AND Book in PDF, Epub and Kindle

This open access book analyses intellectual property and innovation governance in the development of six key industries in India and China. These industries are reflective of the innovation and economic development of the two economies, or of vital importance to them: the IT Industry, the film industry, the pharmaceutical industry, plant varieties and food security, the automobile industry, and the sharing economy. The analysis extends beyond the domain of IP law, and includes economics and policy analysis. The overarching concerns of the book are how the examined industries have developed in the two countries, what role state innovation policy and/or IP policy has played in such development, what the nature of the state innovation policy/IP policy is, whether such policy has been causal, facilitating, crippling, co-relational, or simply irrelevant, and whether there is a possibility of synergy between the two economies. The book also inquires as to why and how one specific industry has developed in one country and not in the other, and what India and China can learn from each other. The book provides a real-life understanding of how IP laws interact with innovation and economic development in the six selected economic sectors in China and India. The reader can also draw lessons from the success or failure of these sectors. --

Contemporary Issues in Pharmaceutical Patent Law

Contemporary Issues in Pharmaceutical Patent Law
Author: Bryan Mercurio,Daria Kim
Publsiher: Taylor & Francis
Total Pages: 249
Release: 2017-02-17
Genre: Law
ISBN: 9781317389798

Download Contemporary Issues in Pharmaceutical Patent Law Book in PDF, Epub and Kindle

This collection reflects on contemporary and contentious issues in international rulemaking in regards to pharmaceutical patent law. With chapters from both well-established and rising scholars, the collection contributes to the understanding of the regulatory framework governing pharmaceutical patents as an integrated discipline through the assessment of relevant laws, trends and policy options. Focusing on patent law and related pharmaceutical regulations, the collection addresses the pressing issues governments face in an attempt to resolve policy dilemmas involving competing interests, needs and objectives. The common theme running throughout the collection is the need for policy and law makers to think and act in a systemic manner and to be more reflective and responsive in finding new solutions within and outside the patent system to the long-standing problems as well as emerging challenges